RGN
Regentis Biomaterials
RGNT • AMEX • Stock Fundamentals
Regentis Biomaterials is a medical - instruments & supplies company in the healthcare sector trading on AMEX, led by CEO Ehud Geller, with a market cap of $11.2M.
Market Cap$11.2M
CEOEhud Geller
CountryIsrael
Healthcare
Medical - Instruments & Supplies
Financials
RGN
Regentis Biomaterials FAQ
Common questions about Regentis Biomaterials
Regentis Biomaterials (RGNT) has a market capitalization of $11.2M and trades on AMEX.